Roche’s Xofluza Can Reduce Flu Transmission, Giving It Potential Market Boost
The company said the CENTERSTONE study marked the first time a global Phase III trial showed reduced transmission of influenza.
The company said the CENTERSTONE study marked the first time a global Phase III trial showed reduced transmission of influenza.